Global Spinal Pumps Market – Industry Trends and Forecast to 2029

Market Analysis and Size

The growing number of movement disorders, such as spinal and brain injuries, multiple sclerosis, and cerebral palsy, necessitates the use of spinal pumps. These problems necessitate long-term treatment, which may include the use of spinal pump devices to alleviate persistent pain in the targeted disorder. In addition, the older population is more vulnerable to the diseases listed above.

Data Bridge Market Research analyses that the spinal pumps market which was USD  284.50  billion in 2021, would rocket up to USD 456.88 million by 2029, and is expected to undergo a CAGR of 6.10% during the forecast period 2022 to 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Report Scope and Market Segmentation      

Market Definition

Spinal pumps use an implanted pump to deliver pain medicine directly to the intrathecal area around the spinal cord. During the forecast period, technological improvements such as coupling programmable external devices with pumps that enable regulated release of small amounts of medication are expected to drive demand for these pain alleviating solutions. Additionally, spinal pumps are utilised to manage chronic pain associated with osteoporosis and pain associated with failed back surgery.

Spinal Pumps Market Dynamics

Drivers

• Government initiatives in implementing spinal pumps in pain management

The region's market is predicted to be driven by the presence of a significant number of health-care organisations, encouraging government attempts to utilise spinal pumps in pain management, and constantly refining reimbursement scenarios. The market is likely to be propelled by favourable reimbursement policies in this region and a regulatory structure that prioritises patient safety while maintaining high treatment efficacy standards. Due to improved health-care processes, Europe is expected to be the second largest market for spinal pumps. Furthermore, the region's industry is propelled by a growth in the ageing population. The main aspect that boosts the industry is the improvement of health-care infrastructure.

• Technological innovations

With technical advancements such as the introduction of programmable external devices with pumps that allow for the regulated release of low pharmaceutical dosages, the demand for these pain-relieving solutions is expected to increase. Furthermore, these advancements have led to the development of intrathecal pumps, which have significantly reduced the occurrence of adverse events typically associated with intravenous and oral drug administration routes; the higher drug efficacy achieved with sustained release of smaller drug doses via these spinal pumps is expected to provide lucrative growth opportunities for the industry.

• Innovative technologies including targeted drug delivery systems

These advanced pain treatment options are based on cutting-edge technologies such as targeted drug delivery systems (DDS), which allow for effective pain targeting, micro-dose infusions, which reduce drug pharmacodynamic effects, and patient-controlled devices, which give patients more control over their treatment. The accompanying benefits of the aforementioned advances, such as faster recovery rates and an enhanced safety profile, resulted in better patient outcomes, which are expected to promote patient and physician preference for these devices in the future.

Opportunities

Painful spasticity, such as that observed in multiple sclerosis, is also treated with spinal pumps. Furthermore, advances in spinal pumps have considerably reduced the occurrence of adverse effects commonly associated with oral and intravenous drug administration. Higher therapeutic efficacy achieved with sustained release of smaller drug dosages via spinal pumps is expected to create considerable potential for enterprises during the projected period.

Restraints/Challenges

However, side effects such as spinal fluid leak, severe skin reactions, and headache are expected to hamper market growth.

This spinal pumps market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the spinal pumps market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Spinal Pumps Market Scope

The spinal pumps market is segmented on the basis of product type, application and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product

• Implantable pump with continuous flow
• Implantable pump with bolus-Variable flow

Application

• Spasticity Management
• Pain Management
• Non-Malignant Pain
• Malignant Pain

End-user

• Hospitals
• ASCs
• Clinics
• Long Term Care Centers
• Alternate Care Centers

Spinal Pumps Market Regional Analysis/Insights

The spinal pumps market is analysed and market size insights and trends are provided by country, product type, application and end-user as referenced above.

The countries covered in the spinal pumps market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the market due to clearly defined reimbursement models in this region and the efficient regulatory framework.

Asia-Pacific is expected to grow at the fastest CAGR of more than 6.10 % during the forecast period, due to rapidly improving healthcare infrastructure and rising patient awareness of alternative treatment options.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Competitive Landscape and Spinal Pumps Market Share Analysis

The spinal pumps market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to spinal pumps market.

Some of the major players operating in the spinal pumps market are:

• Medtronic (Ireland)
• FlowonixMedical, Inc. (U.S)
• Tricumed Medizintechnik GmbH (Germany)
• DePuy Synthes (U.S)
• Teleflex, Incorporated (U.S)
• Smiths Group Plc (U.K)
• Johnson & Johnson Private Limited (U.S)
• BD (U.S)
• Tricumed Medizintechnik GmbH (Germany)

SKU-68596